Category: Abiomed Inc.Syndicate content

CRM: BSX's gain is STJ's loss | Medtech Wall Street news for the week of March 23, 2015

March 26, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy

CRM: Boston Scientific's gain is St. Jude Medical's loss

March 20, 2015 by Brad Perriello

UPDATE: Abiomed soars to new all-time high on FDA nod

March 24, 2015 by Brad Perriello

The FDA's approval of Abiomed's flagship Impella 2.5 heart pump sends the company's stock up 18% to an all-time high.

UPDATE: Abiomed soars to new all-time high on FDA nod

MDT's Ev3 pays $1.3m in whistleblower suit | Medtech legal news for the week of February 16, 2015

February 16, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; Medtronic settles another whistleblower suit for $2.8m; Ex-NFL great Gault must face SEC fraud charges; Appeals court upholds Abiomed win in shareholders lawsuit; Pelvic mesh lawsuits: Boston Scientific wants 700 Philly cases sent to federal court

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Appeals court upholds Abiomed win in shareholders lawsuit

February 9, 2015 by Brad Perriello

A federal appeals court upholds Abiomed's win in a shareholders lawsuit accusing the company of inflating its stock price with rosy predictions for its flagship Impella 2.5 heart pump.

Appeals court upholds Abiomed win in shareholders lawsuit

Abiomed (NSDQ:ABMD) logged another win in a shareholders lawsuit accusing it and its management of misleading investors over the prospects for its flagship Impella 2.5 heart pump.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Asante Solutions sets terms for pending IPO | Medtech Wall Street news for the week of January 26, 2015

January 29, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger

Diabetes: Asante Solutions sets IPO terms

January 23, 2015 by Brad Perriello

Abiomed surges on Q3 numbers, FDA nod

January 28, 2015 by Brad Perriello

Abiomed shares surge to an all-time high after the heart pump maker crushes expectations with its fiscal 3rd-quarter results and raises its outlook for the rest of fiscal 2015.

Abiomed surges on Q3 numbers, FDA nod

Abiomed (NSDQ:ABMD) shares surged to an all-time high today after the heart pump maker crushed expectations for its fiscal 3rd quarter and raised its outlook on the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA approves Abiomed's Impella RP

January 27, 2015 by Brad Perriello

Abiomed wins a humanitarian device exemption for its Impella RP

FDA approves Abiomed's Impella RP

Abiomed (NSDQ:ABMD) today said the FDA approved a humanitarian device exemption for its Impella RP heart pump, calling the device the 1st FDA-approved percutaneous, single-access pump for supporting the heart's right ventricle.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.